India Launches First Indigenous Antibiotic
On 20th November 2024, India's first indigenous antibiotic – Nafithromycin – developed to fight drug-resistant infections, was launched.
Key Points
- Indigenous Innovation: Nafithromycin, developed with support from the Biotechnology Industry Research Assistance Council (BIRAC) and brought to market by Wockhardt under the name Miqnaf, is the first antibiotic developed in India to combat Antimicrobial Resistance (AMR).
- Targeting Pneumonia: It is designed to treat Community-Acquired Bacterial Pneumonia (CABP), a severe illness caused by drug-resistant bacteria, particularly affecting vulnerable populations such as children, the elderly, and immunocompromised individuals.
- Efficacy: Nafithromycin is ten times more effective than existing drugs like azithromycin and offers superior safety ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Sunlight-Powered Self-Charging Energy Storage Device
- 2 Carbon Capture, Utilisation and Storage (CCUS)
- 3 WHO Prequalifies Novel Oral Polio Vaccine Type 2 (nOPV2)
- 4 VoicERA on BHASHINI National Infrastructure
- 5 AI@Work
- 6 Indigenous Td Vaccine Launched
- 7 INCOIS Launches Three Ocean Information Services
- 8 L&T Wins Contract to Build India’s LIGO Observatory in Maharashtra
- 9 Solid Fuel Ducted Ramjet (SFDR) Technology
- 10 Agni-III Missile Test: India Validates Strategic Deterrence Capability
